Compare ESQ & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ESQ | AMPH |
|---|---|---|
| Founded | 2006 | 1996 |
| Country | United States | United States |
| Employees | N/A | 1976 |
| Industry | Commercial Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 941.0M | 1.0B |
| IPO Year | 2017 | 2005 |
| Metric | ESQ | AMPH |
|---|---|---|
| Price | $123.39 | $26.19 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $120.33 | $28.38 |
| AVG Volume (30 Days) | 175.4K | ★ 387.8K |
| Earning Date | 04-23-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.76% | N/A |
| EPS Growth | ★ 14.20 | N/A |
| EPS | ★ 2.89 | 0.81 |
| Revenue | N/A | ★ $719,887,000.00 |
| Revenue This Year | $35.15 | $6.90 |
| Revenue Next Year | $39.09 | $4.64 |
| P/E Ratio | $42.62 | ★ $32.43 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $92.39 | $16.65 |
| 52 Week High | $134.65 | $29.52 |
| Indicator | ESQ | AMPH |
|---|---|---|
| Relative Strength Index (RSI) | 56.90 | 77.09 |
| Support Level | $103.79 | $25.53 |
| Resistance Level | $125.40 | $29.40 |
| Average True Range (ATR) | 2.81 | 0.88 |
| MACD | 0.58 | 0.17 |
| Stochastic Oscillator | 72.38 | 90.18 |
Esquire Financial Holdings Inc is a financial holding company operating as a full service commercial bank. It serves the financial needs of the litigation industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The bank offers tailored financial and payment processing solutions to the litigation community and their clients as well as dynamic and flexible payment processing solutions to small business owners. It operates in one operating segment, that of community banking.
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has one reportable segment: pharmaceutical products. Geographically, the business presence of the firm is seen in the United States, China, and France, of which the U.S. accounts for the majority of the revenue.